Continue the Conversation: Social Media at the AACR Annual Meeting
Guest Post by Raymond DuBois, MD, PhD Arizona State University Biodesign Institute
Guest Post by Raymond DuBois, MD, PhD Arizona State University Biodesign Institute
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
Hear from AACR President Carlos L. Arteaga, MD, and Annual Meeting Program Committee Chairperson Lewis C. Cantley, PhD, about...
Supreme Court Justice Ruth Bader Ginsburg is not among us today. Sadly, we lost this iconic, trailblazing leader, who was the...
AACRoC in Brazil let young investigators learn from cancer research experts during programs in São Paulo and Ribeirão Preto.
As the COVID-19 pandemic swept the globe this spring, the American Association for Cancer Research (AACR) launched a major...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...
We’re closing out 2021 on the blog with Editors’ Picks, our monthly staple featuring articles handpicked by the editors of the AACR...
In just over a month, the Georgia World Congress Center in Atlanta will host the American Association for Cancer...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
As the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved got underway...
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
As the coronavirus pandemic took root in the United States, many hospitals and cancer centers temporarily suspended treatments and...
This year alone, an estimated 1.8 million people will hear their doctor say they have cancer. The individual impact...
Renowned prostate cancer researcher Folakemi T. Odedina, PhD, took the stage at the AACR Conference on the Science of...
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...
Party With a Purpose will honor Penn surgeon Jeffrey Drebin and will donate funds from its gala to the...
One year, to the day, after winning the Nobel Prize in Chemistry for her groundbreaking work on the genetic...
The editors of the 10 AACR journals have selected a handful of must-read articles from the July issues. The...
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...
During a conference known for its emphasis on basic and translational science, a panel discussion on the Affordable Care...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
The lung cancer death rate—the number of lung cancer deaths per 100,000 U.S. men and women—has been decreasing slowly...
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...
On Wednesday, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report. Now in its 11th year, the report details advances in the cancer research...
When a patient receives a cancer diagnosis, doctors may perform genetic testing to determine what drives the cancer, potentially...